RT Journal Article
SR Electronic
T1 Continuing Medical Education Underrepresents United States’ Leading Public Health Concerns
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.03.20225623
DO 10.1101/2020.11.03.20225623
A1 Berry, Nicholas A.
A1 Fumo, Nicole E.
A1 Berry, Bruce B.
YR 2020
UL http://medrxiv.org/content/early/2020/11/04/2020.11.03.20225623.abstract
AB Introduction Continuing medical education (CME) is beneficial to physicians in managing public health problems, yet CME courses rarely address these topics. The purpose of our study was to assess whether leading public health problems, in alignment with their burdens on society, have a proportionate amount of CME opportunities for healthcare professionals.Methods We reviewed all of the CME courses offered by the top 10 research and top 10 primary care medical schools from January 1, 2019 through June 30, 2019 for CME hours directed toward the leading public health problems: obesity, smoking, substance abuse, heart disease, COPD, lung cancer, back pain, depression, and diabetes.Results Of 9355 total CME course hours, dedicated course time, along with the number of individuals affected, and the cost to society, respectively were: obesity 118 (1.3%) hours, 93 million, $147 billion, tobacco cessation 75 (0.8%) hours, 34 million, $300 billion, and substance abuse 157 (1.7%) hours, 43 million, $300 billion.Discussion Public health problems were grossly underrepresented in the amount of dedicated course time compared to their burden on society. More CME courses offerings addressing management of the leading public health problems would likely reduce the burden of illnesses associated with those conditions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNO payments received by any authors or institutions. No external funding received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB exempt, data used in public domain, no protected health information used.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data available in the public domain and upon request to the corresponding author.